Chairs: 

• Bruno Sangro, Director of the Liver Unit and Co-Director of the HPB Oncology Area at Clínica Universidad de Navarra in Pamplona, Spain
  

• Valerie Chew, Principal Investigator, Duke-NUS Medical School, Singapore
  

Speakers:

• How can animal models help better understand primary and secondary resistance to immune checkpoint inhibitor therapy?
  Tim Greten, Senior Investigator, Thoracic and Gastrointestinal Oncology Branch, and head, Gastrointestinal Malignancy Section, National Cancer Institute Center for Cancer Research, Bethesda, USA

• Combination Strategies to Address Immune Checkpoint Inhibitor Resistance in Advanced HCC
  R. Kate Kelley, Professor of Clinical Medicine in the Department of Medicine at the University of California, San Francisco(UCSF) and Helen Diller Family Comprehensive Cancer Center (HDFCCC), USA

• Insight from neoadjuvant and adjuvant trials of immunotherapy
  Chiun Hsu, Professor, Department of Oncology, National Taiwan University Hospital/Graduate Institute of Oncology, National Taiwan University College of Medicine, Taiwan